Tumor markers in clinical use

SMK Gamage*, Chamath Ranaweera, Tracie Cheng, Sharmin Aktar, Vinod Gopalan, Farhadul Islam

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterResearchpeer-review


Despite ever-growing experimental evidence for the utility of a wide range of tumour markers, only a handful are understood to be useful in clinical applications. Tumour markers are useful for screening and diagnosis of cancers, prognostication, guiding treatment pathways and post-treatment surveillance studies. The tumour makers play a significant role in cancer care and the markers included in the current treatment guidelines will be discussed in detail in this chapter. The utility of the tumour markers in the management of colorectal, breast, thyroid, hepatobiliary, pancreatic, ovarian, testicular, neuroendocrine and prostate cancer are detailed herein to provide an update on the current use of tumour markers in the clinical settings.
Original languageEnglish
Title of host publicationCurrent Cancer Biomarkers
PublisherBentham Science Publishers
Number of pages22
Publication statusPublished - Jan 2023
Externally publishedYes


Dive into the research topics of 'Tumor markers in clinical use'. Together they form a unique fingerprint.

Cite this